| Title : Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma - Eager_2009_BMC.Cancer_9_263 |
| Author(s) : Eager RM , Cunningham CC , Senzer NN , Stephenson J, Jr. , Anthony SP , O'Day SJ , Frenette G , Pavlick AC , Jones B , Uprichard M , Nemunaitis J |
| Ref : BMC Cancer , 9 :263 , 2009 |
| Abstract : Eager_2009_BMC.Cancer_9_263 |
| ESTHER : Eager_2009_BMC.Cancer_9_263 |
| PubMedSearch : Eager_2009_BMC.Cancer_9_263 |
| PubMedID: 19643020 |
Eager RM, Cunningham CC, Senzer NN, Stephenson J, Jr., Anthony SP, O'Day SJ, Frenette G, Pavlick AC, Jones B, Uprichard M, Nemunaitis J (2009)
Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma
BMC Cancer
9 :263
Eager RM, Cunningham CC, Senzer NN, Stephenson J, Jr., Anthony SP, O'Day SJ, Frenette G, Pavlick AC, Jones B, Uprichard M, Nemunaitis J (2009)
BMC Cancer
9 :263